Earnings Preview: Agios Pharmaceuticals

Agios Pharmaceuticals (NASDAQ:AGIO) will release its quarterly earnings report on Thursday, 2024-10-31. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Agios Pharmaceuticals to report an earnings per share (EPS) of $-1.01.

Anticipation surrounds Agios Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Overview of Past Earnings

Last quarter the company missed EPS by $0.10, which was followed by a 1.21% drop in the share price the next day.

Here's a look at Agios Pharmaceuticals's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-1.59

-1.65

-1.65

-1.70

EPS Actual

-1.69

-1.45

-1.72

-1.64

Price Change %

-1.0%

-0.0%

-1.0%

7.000000000000001%

Analysts' Perspectives on Agios Pharmaceuticals

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Agios Pharmaceuticals.

Analysts have given Agios Pharmaceuticals a total of 5 ratings, with the consensus rating being Outperform. The average one-year price target is $53.6, indicating a potential 14.46% upside.

Analyzing Ratings Among Peers

The following analysis focuses on the analyst ratings and average 1-year price targets of Veracyte, Catalyst Pharmaceuticals and Geron, three prominent industry players, providing insights ...